MAGICL CYFRA21-1
- UID
- IMP/IVD/2019/000403_b4d8b225108d4d198d73ad6b7c43c4e4_b4ee0ad1f5fbcbe1e2f56f9de1fd8fc2
- Device class
- Class B
- Brand name
- CLIA
- License holder
- M/s. Reckon Diagnostics Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- MAGICL CYFRA21-1 (CLIA) is intended for the in vitro quantitative determination of cytokeratin 19 fragment (CLIA) in human serum and plasma. Clinically, it is mainly used for curative effect observation and recurrence monitoring in patients with non-small cell lung cancer (CLIA)
MAGICL CYFRA21-1 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000403_b4d8b225108d4d198d73ad6b7c43c4e4_b4ee0ad1f5fbcbe1e2f56f9de1fd8fc2. This device is marketed under the brand name CLIA. The license holder is M/s. Reckon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.